Predicting Response to CDK4/6 Inhibitors in Breast Cancer

被引：0
作者：
Schultz, Emily [1 ]
Hamilton, Deanna [1 ]
Wang, Jianxin [1 ]
Witkiewicz, Agnieszka [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
220
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [11] Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response
    Guarducci, Cristina
    Bonechi, Martina
    Boccalini, Giulia
    Benelli, Matteo
    Risi, Emanuela
    Di Leo, Angelo
    Malorni, Luca
    Migliaccio, Ilenia
    [J]. BREAST CARE, 2017, 12 (05) : 304 - 308
  • [12] CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer
    Li, Qing
    Razavi, Pedram
    Li, Zhiqiang
    Paula, Arnaud F. Da Cruz
    Brogi, Edi
    Scaltriti, Maurizio
    Reis-Filho, Jorge S.
    Chandarlapaty, Sarat
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [13] IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER
    Petroni, Giulia
    Gouin, Kenneth
    Martinez, Aitziber Buque
    Knott, Simon
    Formenti, Silvia
    Galluzzi, Lorenzo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A763 - A763
  • [14] An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
    Marie Robert
    Jean-Sébastien Frenel
    Emmanuelle Bourbouloux
    Dominique Berton Rigaud
    Anne Patsouris
    Paule Augereau
    Carole Gourmelon
    Mario Campone
    [J]. Drugs, 2018, 78 : 1353 - 1362
  • [15] Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment
    Ballestin, Sonia Santander
    Labena, Maria Abadia
    Avedillo-Salas, Ana
    Continente, Cristina Marco
    Blazquez, Marina Arribas
    Bartolome, Maria Jose Luesma
    [J]. CANCERS, 2025, 17 (05)
  • [16] Position paper on CDK4/6 inhibitors in early breast cancer
    Michael Gnant
    Christian F. Singer
    Gabriel Rinnerthaler
    Georg Pfeiler
    Daniel Egle
    Marija Balic
    Rupert Bartsch
    [J]. memo - Magazine of European Medical Oncology, 2023, 16 : 135 - 144
  • [17] Position paper on CDK4/6 inhibitors in early breast cancer
    Gnant, Michael
    Singer, Christian F.
    Rinnerthaler, Gabriel
    Pfeiler, Georg
    Egle, Daniel
    Balic, Marija
    Bartsch, Rupert
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (02) : 135 - 144
  • [18] Accessibility of CDK4/6 inhibitors for breast cancer patients in the Netherlands
    Luyendijk, Marianne
    Blommestein, Hedwig
    Jager, Agnes
    Siesling, Sabine
    Uyl-de Groot, Carin
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [19] Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
    Wu, Yanmei
    Zhang, Yu
    Pi, Hao
    Sheng, Yuan
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3477 - 3487
  • [20] CDK4/6 inhibitors in advanced breast cancer, what is beyond?
    Mohammed, Amrallah A.
    Rashied, Hanaa
    Elsayed, Fifi Mostafa
    [J]. ONCOLOGY REVIEWS, 2019, 13 (02) : 125 - 133
12345